Market Highlights
- Pfizer recently announced plans to shut down its operations at 3200 Walnut Street in Boulder due to declining vaccine sales following the COVID pandemic.
- ARCA Biopharma and Oruka Therapeutics have agreed to merge, with plans to go public. Oruka will become a whollyowned subsidiary of ARCA.
- Enveda Biosciences, a pioneering drug discovery company leveraging medicinal plants, has raised $174.0 million to advance its lead compounds toward clinical candidacy, targeting several critical pathways and objectives.